Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3976660 | 0.85 | ADRB2 (0.44) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL3975347 | 0.81 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL14753819 | 0.79 | SMN1; SMN2 (0.46) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL3978923 | 0.79 | CA12 (0.43) | ALDH1A1MEN1KMT2AADRB2ADRB1 | |
| SCHEMBL3981952 | 0.78 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL13353223 | 0.78 | HTT (0.41) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL13321395 | 0.78 | KMT2A (0.41) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL11927404 | 0.77 | L3MBTL1 (0.51) | HTTMAPT | |
| SCHEMBL13885595 | 0.77 | MEN1 (0.39) | ALDH1A1MEN1KMT2AADRB2ADRB1 | |
| SCHEMBL3974397 | 0.76 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2MEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367743-B2 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | BASF SE (DE) | 2013-02-05 | — | — | US | disclosed |
| US-8367743-B2 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | BASF SE (DE) | 2013-02-05 | — | — | US | disclosed |
| US-8367743-B2 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | BASF SE (DE) | 2013-02-05 | — | — | US | disclosed |
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | IGM GROUP B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | IGM GROUP B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | IGM GROUP B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
| WO-2009050116-A2 | ADHESION PROMOTING PHOTOINITIATORS FOR UV CURED COATINGS OVER METAL SURFACES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009050116-A2 | ADHESION PROMOTING PHOTOINITIATORS FOR UV CURED COATINGS OVER METAL SURFACES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | CDH1, PCNA, VCAM1 | ALDH1A1 302/4885SMN1; SMN2 2548/4885MEN1 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.